Anti-HIV-1 activities in extracts from some medicinal plants as assessed in an in vitro biochemical HIV-1 reverse transcriptase assay

被引:17
作者
Kanyara, JN
Njagi, ENM
机构
[1] Kenya Govt Med Res Ctr, KEMRI, Nairobi, Kenya
[2] Kenyatta Univ, Nairobi, Kenya
关键词
HIV-1; reverse transcriptase assay; medicinal plants; extracts; anti-HIV activity; IC50;
D O I
10.1002/ptr.1536
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An in vitro HIV-1 reverse transcriptase (RT) assay was used for screening of anti-HIV activity of extracts obtained from some Kenyan medicinal plants. The assay utilises [H-3]-methyl thymidine triphosphate (dTTP) as the enzyme substrate and polyadenylic acid oligodeoxythymidyllic acid [poly(rA).p(dT)(12-18)] as the template-primer dimmer. This assay was optimised and standardised with respect to the various experimental parameters in a microtiter plate methodology. The assay was then applied to test for potential antiviral activities of several Kenyan medicinal plant extracts and the concentrations producing 50% inhibition (IC50) of the HIV-1 RT were determined. This assay is described in this report and results obtained with some of the extracts are presented. Copyright (c) 2005 John Wiley & Sons, Ltd.
引用
收藏
页码:287 / 290
页数:4
相关论文
共 23 条
[11]  
HAMMER SM, 1994, J ACQ IMMUN DEF SYND, V7, pS24
[12]   Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy [J].
Harrigan, PR ;
Stone, C ;
Griffin, P ;
Nájera, I ;
Bloor, S ;
Kemp, S ;
Tisdale, M ;
Larder, B .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (03) :912-920
[13]   Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: Results of the TARGET study [J].
Henry, K ;
Wallace, RJ ;
Bellman, PC ;
Norris, D ;
Fisher, RL ;
Ross, LL ;
Liao, QM ;
Shaefer, MS .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) :571-578
[14]   CHEMOTHERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS - CURRENT PRACTICE AND FUTURE-PROSPECTS [J].
HIRSCH, MS .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) :845-857
[15]   Compounds with anti-HIV activity from plants [J].
Houghton, PJ .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (06) :601-604
[16]   Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients [J].
Khanna, N ;
Klimkait, T ;
Schiffer, V ;
Irigoyen, J ;
Telenti, A ;
Hirschel, B ;
Battegay, M .
AIDS, 2000, 14 (07) :791-799
[17]  
Kokwaro J.O., 1993, MED PLANTS E AFRICA, V2nd
[18]   ANTIVIRAL TRADITIONAL MEDICINES AGAINST HERPES-SIMPLEX VIRUS (HSV-1), POLIOVIRUS, AND MEASLES-VIRUS IN-VITRO AND THEIR THERAPEUTIC EFFICACIES FOR HSV-1 INFECTION IN MICE [J].
KUROKAWA, M ;
OCHIAI, H ;
NAGASAKA, K ;
NEKI, M ;
XU, HX ;
KADOTA, S ;
SUTARDJO, S ;
MATSUMOTO, T ;
NAMBA, T ;
SHIRAKI, K .
ANTIVIRAL RESEARCH, 1993, 22 (2-3) :175-188
[19]  
NEUZIL KM, 1994, AM J MED SCI, V7, P368
[20]   MULTIPLE EFFECTS OF INTERFERON ON THE REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
PITHA, PM .
ANTIVIRAL RESEARCH, 1994, 24 (2-3) :205-219